Access to treatments | DEEP Diagnostics

Home > Projects > Access to treatments | DEEP Diagnostics

About Access to treatments | DEEP Diagnostics

A global lighthouse project providing personalized treatment plans by merging Whole Genome Sequencing with drug screening, focusing initially on glioblastoma and pancreatic cancer, but we will broaden the perspective.

DEEP Diagnostics is an Inspire2Live lighthouse project created to provide a personalised individual treatment and medicine plan i.e., this patient, with their specific disease, at this moment, needs this particular treatment.

As part of our project, we have started working with patients suffering from a type of brain tumour known as glioblastoma and with patients diagnosed with pancreatic cancer. These two unmet medical needs deserve so much more attention than they have received until now.

We’ve decided not to apply alone, but to be part of projects, set up by other groups and be very critical on the personalized perspective of these initiatives.

A good example is ONCODE Accelerator. Inspire2Live works together with this European initiative closely.